ACTRIMS: Americas Committee for Treatment and Research in Multiple Sclerosis
Conference Coverage
Smartphone technology helps to detect, track eye changes in MS
DALLAS – The testing is low-cost, large-scale, and enables clinicians to study genotype-phenotype comparisons.
Conference Coverage
Study eyes serious adverse events from long-term rituximab use in MS
DALLAS – No patient experienced an infusion reaction requiring hospitalization.
Conference Coverage
Optical coherence tomography emerging as a promising biomarker for MS
DALLAS – To date, there has been a paucity of studies assessing the effects of DMTs on retinal layer thickness.
Conference Coverage
New data bolster latitude’s association with MS prevalence
DALLAS – After integrating data from 94 new studies, “the latitudinal gradient in MS prevalence ... significantly enhanced in magnitude,”...
Conference Coverage
Genetic signature helps identify those at risk of MS
DALLAS – “In this effort to redefine this disease and when it starts, these molecular and cellular studies are becoming very important.”
Conference Coverage
Which comorbidities most diminish quality of life in patients with MS?
DALLAS – Systemic lupus erythematosus, depression, and hyperthyroidism may have large effects on health-related quality of life in patients with...
Video
MRI is a critical part of the MS precision medicine toolkit
DALLAS – As the central vein sign emerges as a candidate biomarker, researchers are tracking very early lesions.
Conference Coverage
Survey of MS patients reveals numerous pregnancy-related concerns
DALLAS – Of those who became pregnant following diagnosis, 20% reported postpartum depression or anxiety.
Conference Coverage
Teriflunomide transmission can occur in female partners of men taking the drug
DALLAS – Women who had low detectable levels of teriflunomide did not engage in more frequent sexual intercourse than did women with undetectable...
Conference Coverage
Neurologists grappling with patients who embrace ‘stem cell tourism’
DALLAS – The unethical practice of offering unproven cellular preparations to patients is rising in multiple sclerosis.
Conference Coverage
Evaluations for possible MS often turn up one of its many mimics
DALLAS – At two multiple sclerosis (MS) centers, 74% of patients referred for a possible diagnosis of MS did not have the disease.
News
Barancik award winner probes role of fibrinogen in MS
DALLAS – It’s a chicken-and-egg puzzle to tease out how fibrinogen behaves in the brain.
News
From bedside to bench to bedside: Derisking MS research
DALLAS – Research starting with clinical observations can increase the yield.
Video
MS research: “Our patients can’t wait” for conventional techniques
DALLAS – Harnessing big data helps with precision assessment of MS phenotype.